Genprex (GNPX) EBT (2016 - 2025)

Genprex (GNPX) has 9 years of EBT data on record, last reported at -$3.3 million in Q3 2025.

  • For Q3 2025, EBT rose 22.52% year-over-year to -$3.3 million; the TTM value through Sep 2025 reached -$16.3 million, up 28.16%, while the annual FY2024 figure was -$21.1 million, 31.55% up from the prior year.
  • EBT reached -$3.3 million in Q3 2025 per GNPX's latest filing, up from -$4.7 million in the prior quarter.
  • Across five years, EBT topped out at -$3.3 million in Q3 2025 and bottomed at -$9.2 million in Q1 2023.
  • Average EBT over 5 years is -$5.7 million, with a median of -$5.8 million recorded in 2022.
  • Peak YoY movement for EBT: plummeted 78.67% in 2022, then skyrocketed 44.21% in 2024.
  • A 5-year view of EBT shows it stood at -$6.8 million in 2021, then rose by 3.36% to -$6.5 million in 2022, then grew by 9.12% to -$5.9 million in 2023, then increased by 26.94% to -$4.3 million in 2024, then increased by 22.8% to -$3.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were -$3.3 million in Q3 2025, -$4.7 million in Q2 2025, and -$4.0 million in Q1 2025.